Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome

World Medical Association Declaration of Helsinki

JAMA · 2013 · 27.3K citations

Biomedical Ethic, Ethical Principles, Research Ethics +19

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

John Koreth, Ken‐ichi Matsuoka, Haesook T. Kim et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

Yohei Iwata, Takashi Matsushita, Mayuka Horikawa et al. · Blood · 2010 · 1.1K citations · Full text

EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

Raphaèle Séror, Philippe Ravaud, Simon Bowman et al. · Annals of the Rheumatic Diseases · 2009 · 910 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +13

Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

David Saadoun, Michèlle Rosenzwajg, Florence Joly et al. · New England Journal of Medicine · 2011 · 728 citations · Full text